Virulence Factors as Targets for Anticryptococcal Therapy
AbstractThe global mortality due to cryptococcosis caused by Cryptococcus neoformans or C. gattii is unacceptably high. Currently available therapies are decades old and may be impacted by drug resistance. Therefore, the need for more effective antifungal drugs for cryptococcosis is evident. A number of Cryptococcus virulence factors have been studied in detail, providing crucial information about the fungal biology and putative molecular targets for antifungals. This review focuses on the use of well-described virulence factors of Cryptococcus as potential anticryptococcal agents. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Azevedo, R.V.D.M.; Rizzo, J.; Rodrigues, M.L. Virulence Factors as Targets for Anticryptococcal Therapy. J. Fungi 2016, 2, 29.
Azevedo RVDM, Rizzo J, Rodrigues ML. Virulence Factors as Targets for Anticryptococcal Therapy. Journal of Fungi. 2016; 2(4):29.Chicago/Turabian Style
Azevedo, Renata V.D.M.; Rizzo, Juliana; Rodrigues, Marcio L. 2016. "Virulence Factors as Targets for Anticryptococcal Therapy." J. Fungi 2, no. 4: 29.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.